← Back to Search

Peer Genetic Coaching for Prostate Cancer

N/A

Recruiting

Led By Amy Leader, DrPh, MPH

Research Sponsored by Thomas Jefferson University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline up to 1 year

Awards & highlights

No Placebo-Only Group

Summary

This trial evaluates if a network of peer genetic coaches can help African American men with prostate cancer get genetic testing they may be unaware of, afford, or feel reluctant to seek due to mistrust.

Who is the study for?

This trial is for African American men over 18 with metastatic prostate cancer or high-risk features, and those with a strong family history of certain cancers. Participants must be comfortable reading and speaking English. It excludes minors, individuals who struggle to understand consent, or have significant anxiety during the consent process.

What is being tested?

The study tests if peer genetic coaches can help overcome disparities in genetic testing among African American men with advanced prostate cancer by providing education, training, discussions, and navigation services to increase their engagement in genetic testing.

What are the potential side effects?

Since this intervention involves educational activities rather than medical treatments or drugs, traditional physical side effects are not expected. However, participants may experience emotional distress or anxiety related to learning about genetic risks.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline up to 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline up to 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline up to 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Secondary study objectives

Change in acceptability/attitude toward genetic counseling and testing

Change in decisional conflict for genetic counseling

Change of genetics knowledge

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Supportive care (training, education, discussion)Experimental Treatment3 Interventions

AIM 1: Peer genetic coaches undergo training and education on study. AIM 2: Patients receive an educational booklet and attend a discussion with a peer genetic coach on study.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Discussion

2021

N/A

~180

Training and Education

2023

N/A

~20